Skip to Main Content

Paper Details

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis.
NPJ Precis Oncol
21
2021
ALK, ALK variant, ALK+, ALK-rearranged lung cancer, NSCLC, circulating tumor DNA, ctDNA, lung cancer, patient, patients, plasma, plasma DNA samples
Author NameAffiliation
Matthias SchlesnerTranslational Lung Research Center Heidelberg, German Center for Lung Research (DZL)
Matthias SchlesnerAugsburg University
Matthias SchlesnerGerman Cancer Research Center (DKFZ)
Matthias SchlesnerTranslational Lung Research Center Heidelberg, German Center for Lung Research (DZL)
Matthias SchlesnerGerman Cancer Research Center (DKFZ)
Matthias SchlesnerAugsburg University
Albrecht StenzingerInstitute of Pathology, Heidelberg University
Albrecht Stenzinger
Holger S??ltmannGerman Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT)
Holger S??ltmannTranslational Lung Research Center Heidelberg, German Center for Lung Research (DZL)
  • 1 - 10

Datasets

Release 1.2